297 related articles for article (PubMed ID: 26935506)
1. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
[TBL] [Abstract][Full Text] [Related]
2. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
3. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
[TBL] [Abstract][Full Text] [Related]
4. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
[TBL] [Abstract][Full Text] [Related]
5. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
6. MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state.
Frottin F; Bienvenut WV; Bignon J; Jacquet E; Vaca Jacome AS; Van Dorsselaer A; Cianferani S; Carapito C; Meinnel T; Giglione C
Oncotarget; 2016 Sep; 7(39):63306-63323. PubMed ID: 27542228
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
8. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.
Kass DJ; Rattigan E; Kahloon R; Loh K; Yu L; Savir A; Markowski M; Saqi A; Rajkumar R; Ahmad F; Champion HC
PLoS One; 2012; 7(4):e35388. PubMed ID: 22509410
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
10. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
12. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.
Kim YJ; Hong S; Sung M; Park MJ; Jung K; Noh KW; Oh DY; Lee MS; Oh E; Shin YK; Choi YL
Oncotarget; 2016 Dec; 7(50):82876-82888. PubMed ID: 27756880
[TBL] [Abstract][Full Text] [Related]
13. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
14. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis.
Kass D; Bridges RS; Borczuk A; Greenberg S
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):193-201. PubMed ID: 17446530
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.
Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ
Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
17. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
[TBL] [Abstract][Full Text] [Related]
18. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
Endo H; Takenaga K; Kanno T; Satoh H; Mori S
J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
[TBL] [Abstract][Full Text] [Related]
19. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
